Scientist to Founder's Avatar

Scientist to Founder

@s2f.bsky.social

Empowering talent to build enduring businesses https://linktr.ee/axialxyz

14 Followers  |  2 Following  |  9 Posts  |  Joined: 13.09.2023  |  1.5616

Latest posts by s2f.bsky.social on Bluesky


Post image

β€œYou can observe a lot by watching”

- Yogi Berra

31.10.2023 14:51 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

"Nature holds the key to our aesthetic, intellectual, cognitive and even spiritual satisfaction."

- E. O. Wilson

30.10.2023 14:16 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

"I see a future in which nature gives us a helping hand. Instead of destroying the natural world, why can't we use it to solve the kinds of problems that we are facing?"

- Frances Arnold

29.10.2023 16:04 β€” πŸ‘ 14    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0

"And most important, have the courage to follow your heart and intuition."

26.10.2023 23:31 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

"Your time is limited, so don't waste it living someone else's life. Don't be trapped by dogma - which is living with the results of other people's thinking. Don't let the noise of others' opinions drown out your own inner voice."

- Steve Jobs

26.10.2023 23:30 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 1    πŸ“Œ 0

TopOMetry systematically learns and evaluates the latent dimensions of single-cell atlases led by Davi Sidarta-Oliveira & Licio Velloso www.biorxiv.org/content/10.1...

28.09.2023 17:35 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Century Therapeutics develops iPSC-derived cell therapies for cancer. Working to design drugs that can better evade identification by the host immune system and potentially allow patients to receive multiple doses of cell therapy. With the idea to get more durable responses.

20.09.2023 16:39 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Enlaza Therapeutics develops covalent biologics. Founded in 2022, the company is developing a new class of protein therapeutics that are engineered to irreversibly lock to disease-related targets. Going after harder-to-drug targets and potentially creating safer/more efficacious treatments

19.09.2023 16:45 β€” πŸ‘ 1    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Scientist Stories: Akiko Iwasaki, Immunology and Antibodies youtu.be/1gFzmoCr3Vk

19.09.2023 16:44 β€” πŸ‘ 5    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Post image

Modular cytokine receptor-targeting chimeras for targeted degradation of cell surface and extracellular proteins www.nature.com/articles/s41...

19.09.2023 16:43 β€” πŸ‘ 14    πŸ” 4    πŸ’¬ 0    πŸ“Œ 0
Post image

Nautilus Biotechnology is proteomics company developing technologies to measure proteoforms. Founded in 2016, Nautilus' platform is designed to detect proteins that are present in very low concentrations. Measuring specific versions of proteins and also detecting them from complex samples.

15.09.2023 16:36 β€” πŸ‘ 4    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0

Founder Stories: Tassos Gianakakos, CEO of MyoKardia youtu.be/Haa6ORz__ig

14.09.2023 17:16 β€” πŸ‘ 7    πŸ” 3    πŸ’¬ 0    πŸ“Œ 0

Geometric deep learning of RNA structure www.science.org/doi/10.1126/...

14.09.2023 17:16 β€” πŸ‘ 5    πŸ” 2    πŸ’¬ 0    πŸ“Œ 0

@s2f is following 2 prominent accounts